Clinical Trial Update: Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

View source ↗

Summary

Mayo Clinic is conducting a study to identify biomarkers that predict cardiotoxicity from cancer therapies; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Status: RECRUITING